Compare VYGR & IMPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | IMPP |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.3M | 234.7M |
| IPO Year | 2015 | 2021 |
| Metric | VYGR | IMPP |
|---|---|---|
| Price | $3.09 | $5.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 404.5K | ★ 461.3K |
| Earning Date | 05-08-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,135,000.00 | N/A |
| Revenue This Year | $34.04 | $51.79 |
| Revenue Next Year | $7.92 | $6.97 |
| P/E Ratio | ★ N/A | $3.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.94 | $3.15 |
| 52 Week High | $5.55 | $6.57 |
| Indicator | VYGR | IMPP |
|---|---|---|
| Relative Strength Index (RSI) | 42.00 | 74.00 |
| Support Level | $2.95 | $4.64 |
| Resistance Level | $3.30 | N/A |
| Average True Range (ATR) | 0.14 | 0.25 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 13.19 | 96.67 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.